Home » Stocks » SLN

Silence Therapeutics PLC (SLN)

Stock Price: $23.00 USD 0.00 (0.00%)
Updated Jan 21, 2021 4:00 PM EST - Market closed
Market Cap 606.90M
Revenue (ttm) 244,000
Net Income (ttm) -19.58M
Shares Out 78.37M
EPS (ttm) -0.78
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a
Trading Day January 21
Last Price $23.00
Previous Close $23.00
Change ($) 0.00
Change (%) 0.00%
Day's Open 23.11
Day's Range 23.00 - 23.00
Day's Volume 3,084
52-Week Range 15.00 - 24.00

News

There are no news available yet.

About SLN

Silence Therapeutics plc focuses on the discovery, development, and delivery of novel RNA therapeutics in hematology, cardiovascular, and other rare and metabolic indications. The company designs short interfering RNA (siRNA) molecules that trigger the RNAi pathway and mediate the degradation of specific target messenger RNAs. It is developing various product candidates, including SLN124 for the treatment of iron overload disorders; SLN360 for the cardiovascular disease with high lipoprotein; and SLN500 for the treatment of complement-mediated ... [Read more...]

Industry
Biotechnology
CEO
David Solomon
Employees
46
Stock Exchange
NASDAQ
Ticker Symbol
SLN
Full Company Profile

Financial Performance

Financial Statements